Thomas Paul Mohr, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 951-765-1772 |
Dr. Sharon Kay Knepfler, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 951-765-1772 |
Veronica Elizabeth Reinherz, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 951-765-1772 |
Jennifer Caroline Keith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 951-765-1772 |
Vidhyalakshmi Koka, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 422 N San Jacinto St, Hemet, CA 92543 Phone: 941-665-1100 Fax: 888-696-2590 |
Donna L Hines, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 866-390-9161 |
Dr. Prasanna Bastola, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1023 E Florida Ave, Hemet, CA 92543 Phone: 951-599-8403 Fax: 951-766-0930 |
Dru Imrie, M.D./PH.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 1285 S State St, Hemet, CA 92543 Phone: 951-765-1777 Fax: 951-765-1772 |
News Archive
The number of countries where iodine deficiency is a public health problem has halved over the past decade, says the World Health Organization (WHO) in a new global report on iodine status.
Heme oxygenase-1 is essential for the growth of blood vessels in the placenta and in establishing blood flow in the umbilical cord. Too little HO-1 can lead to a restriction in the growth of the fetus and even in fetal death and miscarriage. New research published in BioMed Central's open access journal Medical Gas Research has shown that low dose carbon monoxide therapy is able to restore placental function and prevent fetal death in mice, without any detrimental effects.
According to an Access Economics study commissioned by the Alzheimer's Australia the number of Victorian dementia patients will quadruple in the next 40 years. At present the figures stand at 66,000 and are expected to touch 246,000 in 2050. The rise is an alarming 275% and is fueled by population growth, reduced physical activity, and an increasingly ageing population. Alzheimer's Australia warns Victorian Health authorities to start planning for measures to curb the epidemic.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
› Verified 9 days ago